Global Anti-Retroviral Drugs Market Status and Outlook 2018-2025

August 2018 | 136 pages | ID: G1E73F4E91CEN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Cardionet
• GE Healthcare
• Abbott
• AstraZeneca
• Bristol-Myers-Squibb
• Gilead
• Cardiac Science Corp.
• Cardiocom
• Biotelemetry
• GlaxoSmithKline
• Roche

Market by Type

• Protease Inhibitors
• Non-Nucleoside Reverse Transcriptase Inhibitors
• Integrase Inhibitors
• Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors

Market by Application

• Hepatitis
• HIV/AIDS
• Herpes
• Influenza
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Anti-Retroviral Drugs Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Protease Inhibitors
  3.1.2 Non-Nucleoside Reverse Transcriptase Inhibitors
  3.1.3 Integrase Inhibitors
  3.1.4 Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hepatitis
  4.1.2 HIV/AIDS
  4.1.3 Herpes
  4.1.4 Influenza
  4.1.5 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Protease Inhibitors Production by Region
    6.1.1.2 Non-Nucleoside Reverse Transcriptase Inhibitors Production by Region
    6.1.1.3 Integrase Inhibitors Production by Region
    6.1.1.4 Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hepatitis Production by Region
    6.1.2.2 HIV/AIDS Production by Region
    6.1.2.3 Herpes Production by Region
    6.1.2.4 Influenza Production by Region
    6.1.2.5 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Protease Inhibitors Demand by Region
    6.2.1.2 Non-Nucleoside Reverse Transcriptase Inhibitors Demand by Region
    6.2.1.3 Integrase Inhibitors Demand by Region
    6.2.1.4 Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hepatitis Demand by Region
    6.2.2.2 HIV/AIDS Demand by Region
    6.2.2.3 Herpes Demand by Region
    6.2.2.4 Influenza Demand by Region
    6.2.2.5 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Cardionet
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 GE Healthcare
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Abbott
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 AstraZeneca
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Bristol-Myers-Squibb
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Gilead
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Cardiac Science Corp.
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Cardiocom
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Biotelemetry
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 GlaxoSmithKline
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Roche

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Anti-Retroviral Drugs Industry Dynamics & Regulations List
Table Global Anti-Retroviral Drugs Sales Revenue, Cost and Margin, 2015-2018E
Table Global Anti-Retroviral Drugs Market Status by Type 2015-2018E, in USD Million
Table Global Anti-Retroviral Drugs Market Status by Application 2015-2018E, in USD Million
Table Global Anti-Retroviral Drugs Market Status by Application 2015-2018E, in Volume
Table Global Anti-Retroviral Drugs Market by Region 2015-2018E, in USD Million
Table Global Anti-Retroviral Drugs Market Share by Region in 2018, in USD Million
Table Global Anti-Retroviral Drugs Market by Region 2015-2018E, in Volume
Table Global Anti-Retroviral Drugs Market Share by Region in 2018, in Volume
Table Protease Inhibitors Production Value by Region 2015-2018E, in USD Million
Table Protease Inhibitors Production Volume by Region 2015-2018E, in Volume
Table Non-Nucleoside Reverse Transcriptase Inhibitors Production Value by Region 2015-2018E, in USD Million
Table Non-Nucleoside Reverse Transcriptase Inhibitors Production Volume by Region 2015-2018E, in Volume
Table Integrase Inhibitors Production Value by Region 2015-2018E, in USD Million
Table Integrase Inhibitors Production Volume by Region 2015-2018E, in Volume
Table Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors Production Value by Region 2015-2018E, in USD Million
Table Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors Production Volume by Region 2015-2018E, in Volume
Table Hepatitis Production Value by Region 2015-2018E, in USD Million
Table Hepatitis Production Volume by Region 2015-2018E, in Volume
Table HIV/AIDS Production Value by Region 2015-2018E, in USD Million
Table HIV/AIDS Production Volume by Region 2015-2018E, in Volume
Table Herpes Production Value by Region 2015-2018E, in USD Million
Table Herpes Production Volume by Region 2015-2018E, in Volume
Table Influenza Production Value by Region 2015-2018E, in USD Million
Table Influenza Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Protease Inhibitors Market Size by Region 2015-2018E, in USD Million
Table Protease Inhibitors Market Size by Region 2015-2018E, in Volume
Table Non-Nucleoside Reverse Transcriptase Inhibitors Market Size by Region 2015-2018E, in USD Million
Table Non-Nucleoside Reverse Transcriptase Inhibitors Market Size by Region 2015-2018E, in Volume
Table Integrase Inhibitors Market Size by Region 2015-2018E, in USD Million
Table Integrase Inhibitors Market Size by Region 2015-2018E, in Volume
Table Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors Market Size by Region 2015-2018E, in USD Million
Table Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors Market Size by Region 2015-2018E, in Volume
Table Hepatitis Market Size by Region 2015-2018E, in USD Million
Table Hepatitis Market Size by Region 2015-2018E, in Volume
Table HIV/AIDS Market Size by Region 2015-2018E, in USD Million
Table HIV/AIDS Market Size by Region 2015-2018E, in Volume
Table Herpes Market Size by Region 2015-2018E, in USD Million
Table Herpes Market Size by Region 2015-2018E, in Volume
Table Influenza Market Size by Region 2015-2018E, in USD Million
Table Influenza Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalAnti-Retroviral Drugs Forecast by Type 2019F-2025F, in USD Million
Table Anti-Retroviral Drugs Forecast by Type 2019F-2025F, in Volume
Table Anti-Retroviral Drugs Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Anti-Retroviral Drugs Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Anti-Retroviral Drugs Market Forecast by Region 2019F-2025F, in USD Million
Table Anti-Retroviral Drugs Market Forecast by Region 2019F-2025F, in Volume
Table Cardionet Information
Table Anti-Retroviral Drugs Sales, Cost, Margin of Cardionet
Table GE Healthcare Information
Table Anti-Retroviral Drugs Sales, Cost, Margin of GE Healthcare
Table Abbott Information
Table Anti-Retroviral Drugs Sales, Cost, Margin of Abbott
Table AstraZeneca Information
Table Anti-Retroviral Drugs Sales, Cost, Margin of AstraZeneca
Table Bristol-Myers-Squibb Information
Table Anti-Retroviral Drugs Sales, Cost, Margin of Bristol-Myers-Squibb
Table Gilead Information
Table Anti-Retroviral Drugs Sales, Cost, Margin of Gilead
Table Cardiac Science Corp. Information
Table Anti-Retroviral Drugs Sales, Cost, Margin of Cardiac Science Corp.
Table Cardiocom Information
Table Anti-Retroviral Drugs Sales, Cost, Margin of Cardiocom
Table Biotelemetry Information
Table Anti-Retroviral Drugs Sales, Cost, Margin of Biotelemetry
Table GlaxoSmithKline Information
Table Anti-Retroviral Drugs Sales, Cost, Margin of GlaxoSmithKline
Table Roche Information
Table Anti-Retroviral Drugs Sales, Cost, Margin of Roche
Table Global Anti-Retroviral Drugs Sales Revenue by Company 2015-2017, in USD Million
Table Global Anti-Retroviral Drugs Sales Volume by Company 2015-2017, in Volume
Table Global Anti-Retroviral Drugs Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Anti-Retroviral Drugs Picture
Figure Anti-Retroviral Drugs Industry Chain Diagram
Figure Global Anti-Retroviral Drugs Sales Revenue 2015-2018E, in USD Million
Figure Global Anti-Retroviral Drugs Sales Volume 2015-2018E, in Volume
Figure Global Anti-Retroviral Drugs Market Status by Type 2015-2018E, in Volume
Figure North America Anti-Retroviral Drugs Market Size and Growth 2015-2018E, in USD Million
Figure North America Anti-Retroviral Drugs Market Size and Growth 2015-2018E, in Volume
Figure Europe Anti-Retroviral Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Europe Anti-Retroviral Drugs Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Anti-Retroviral Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Anti-Retroviral Drugs Market Size and Growth 2015-2018E, in Volume
Figure South America Anti-Retroviral Drugs Market Size and Growth 2015-2018E, in USD Million
Figure South America Anti-Retroviral Drugs Market Size and Growth 2015-2018E, in Volume
Figure Middle East Anti-Retroviral Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Anti-Retroviral Drugs Market Size and Growth 2015-2018E, in Volume
Figure Africa Anti-Retroviral Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Africa Anti-Retroviral Drugs Market Size and Growth 2015-2018E, in Volume
Figure Global Anti-Retroviral Drugs Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Anti-Retroviral Drugs Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Anti-Retroviral Drugs Sales Price Forecast 2019F-2025F
Figure Global Anti-Retroviral Drugs Gross Margin Forecast 2019F-2025F
Figure Global Anti-Retroviral Drugs Sales Revenue by Company in 2018, in USD Million
Figure Global Anti-Retroviral Drugs Price by Company in 2018
Figure Global Anti-Retroviral Drugs Gross Margin by Company in 2018